Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19.
Cédric GarciaJonathan Au DuongMichael PoëtteAgnès RibesBruno PayreVincent MemierPierre SiéVincent MinvilleSophie VoisinBernard PayrastreVincent BounesPublished in: Blood advances (2022)
Mild thrombocytopenia, changes in platelet gene expression, enhanced platelet functionality, and presence of platelet-rich thrombi in the lung have been associated with thromboinflammatory complications of patients with COVID-19. However, whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gets internalized by platelets and directly alters their behavior and function in infected patients remains elusive. Here, we investigated platelet parameters and the presence of viral material in platelets from a prospective cohort of 29 patients with severe COVID-19 admitted to an intensive care unit. A combination of specific assays, tandem mass spectrometry, and flow cytometry indicated high levels of protein and lipid platelet activation markers in the plasma from patients with severe COVID-19 associated with an increase of proinflammatory cytokines and leukocyte-platelets interactions. Platelets were partly desensitized, as shown by a significant reduction of αIIbβ3 activation and granule secretion in response to stimulation and a decrease of surface GPVI, whereas plasma from patients with severe COVID-19 potentiated washed healthy platelet aggregation response. Transmission electron microscopy indicated the presence of SARS-CoV-2 particles in a significant fraction of platelets as confirmed by immunogold labeling and immunofluorescence imaging of Spike and nucleocapsid proteins. Compared with platelets from healthy donors or patients with bacterial sepsis, platelets from patients with severe COVID-19 exhibited enlarged intracellular vesicles and autophagolysosomes. They had large LC3-positive structures and increased levels of LC3II with a co-localization of LC3 and Spike, suggesting that platelets can digest SARS-CoV-2 material by xenophagy in critically ill patients. Altogether, these data show that during severe COVID-19, platelets get activated, become partly desensitized, and develop a selective autophagy response.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- intensive care unit
- gene expression
- early onset
- tandem mass spectrometry
- simultaneous determination
- red blood cell
- high resolution
- flow cytometry
- liquid chromatography
- oxidative stress
- small molecule
- signaling pathway
- ultra high performance liquid chromatography
- electron microscopy
- cell death
- artificial intelligence
- acute kidney injury
- acute respiratory distress syndrome
- high speed
- single molecule
- mechanical ventilation
- data analysis